Clinical Trial Results: Tezepelumab Efficacy and Safety in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma [Phase 3]

View source ↗

Summary

Phase 3 trial assessing tezepelumab for reducing oral corticosteroid use in adults with oral corticosteroid-dependent asthma; study terminated with posted resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: TERMINATED | Results posted: 2026-06-18